» Articles » PMID: 26865098

Lessons Learned from Cancer Prevention Studies with Nutrients and Non-nutritive Dietary Constituents

Overview
Date 2016 Feb 12
PMID 26865098
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiological studies have observed the association between dietary patterns and the risk of certain types of cancer. Extensive studies have been conducted on the cancer preventive activities of constituents from food and beverages. While laboratory research has shown impressive and promising results, such promising cancer preventive activities have not been demonstrated in many human intervention trials. This article analyzes the major differences between these different types of studies and the limitations of these studies. Animal and cell line studies usually use optimal conditions in order to demonstrate the hypothesized effects, sometimes without considering the human relevance. On the other hand, some clinical trials were designed without a good understanding of the biochemical and pharmacological properties of the agents used. Lessons learned from these studies will be illustrated using vitamin E, β-carotene and selenium as examples for nutrients, and green tea polyphenols as an example for non-nutritive dietary constituents. From the lessons learned, we believe that more interdisciplinary collaboration and integration of laboratory and human studies would effectively advance the field of cancer prevention.

Citing Articles

Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies.

Lekhak N, Bhattarai H Cancer Control. 2024; 31:10732748241302902.

PMID: 39629692 PMC: 11615997. DOI: 10.1177/10732748241302902.


The Nutriepigenome.

Mirisola M Genes (Basel). 2023; 14(11).

PMID: 38002940 PMC: 10671240. DOI: 10.3390/genes14111997.


The Development of Global Cancer Research at the United States National Cancer Institute.

Parascandola M, Pearlman P, Eldridge L, Gopal S J Natl Cancer Inst. 2022; 114(9):1228-1237.

PMID: 35640108 PMC: 9468288. DOI: 10.1093/jnci/djac104.


δ-Tocotrienol is the Most Potent Vitamin E Form in Inhibiting Prostate Cancer Cell Growth and Inhibits Prostate Carcinogenesis in Ptenp-/- Mice.

Wang H, Yan W, Sun Y, Yang C Cancer Prev Res (Phila). 2022; 15(4):233-245.

PMID: 35144931 PMC: 8984964. DOI: 10.1158/1940-6207.CAPR-21-0508.


Critical Appraisal of Large Vitamin D Randomized Controlled Trials.

Pilz S, Trummer C, Theiler-Schwetz V, Grubler M, Verheyen N, Odler B Nutrients. 2022; 14(2).

PMID: 35057483 PMC: 8778517. DOI: 10.3390/nu14020303.


References
1.
Duffield-Lillico A, Dalkin B, Reid M, Turnbull B, Slate E, Jacobs E . Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003; 91(7):608-12. DOI: 10.1046/j.1464-410x.2003.04167.x. View

2.
Ermakova S, Kang B, Choi B, Choi H, Schuster T, Ma W . (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 2006; 66(18):9260-9. DOI: 10.1158/0008-5472.CAN-06-1586. View

3.
Papadimitrakopoulou V, Lee J, William Jr W, Martin J, Thomas M, Kim E . Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol. 2008; 27(4):599-604. PMC: 2645856. DOI: 10.1200/JCO.2008.17.1850. View

4.
Huang P, Chuang H, Chou C, Wang H, Lee S, Yang H . Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1. Sci Signal. 2013; 6(267):ra19. PMC: 3910367. DOI: 10.1126/scisignal.2003816. View

5.
Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A . Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med. 2015; 7(298):298ra117. PMC: 4827609. DOI: 10.1126/scitranslmed.aaa7619. View